CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.5850
-0.0070 (-1.18%)
At close: Mar 13, 2026, 4:00 PM EDT
0.5967
+0.0117 (2.00%)
After-hours: Mar 13, 2026, 4:06 PM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $7.47 million as of March 13, 2026. Its market cap has decreased by -81.36% in one year.
Market Cap
7.47M
Enterprise Value
1.87M
1-Year Change
-81.36%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $7.47M, a decrease of -75.57%. That is a compound annual growth rate of -15.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 6.70M | -58.13% |
| Dec 31, 2025 | 16.00M | -61.17% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artelo Biosciences | 7.99M |
| Alzamend Neuro | 7.76M |
| Pulmatrix | 7.71M |
| Kiora Pharmaceuticals | 7.69M |
| GridAI Technologies | 7.60M |
| Bolt Biotherapeutics | 7.51M |
| Moolec Science | 7.43M |
| Alaunos Therapeutics | 7.37M |